News

Press Release | Jun 28, 2017

Bionano Genomics and Genoptix today announced an exclusive agreement to codevelop diagnostic assays for selected hematologic oncology indications. Bionano will contribute its knowledge of genome structure analysis and its Saphyr system, which is designed to accurately visualize the structure of a genome with a simple DNA sample, isolated directly from cancer cells. The platform can

News | Jun 20, 2017

Another noteworthy feature of emerging managers is that many of them have created new or different models for their firms and for making VC investments. “We leverage a unique, team-based operating partner model of CEO and longtime executive partners who collaborate with us,” said Adele Oliva, Founding Partner of Philadelphia-based healthcare expansion and growth equity

Press Release | Jun 07, 2017

1315 Capital, LLC, an expansion and growth equity firm that invests in commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, announced today the continued expansion of its senior investment team with the addition of Matthew Q. Reber as a Partner. Mr. Reber joins Founding Partners, Adele C. Oliva and Michael Koby, and brings deep

Press Release | Apr 19, 2017

Onkos Surgical, Inc., a specialty medtech company focused on surgical oncology, today announced that it closed a $17.6 million round in Series B funding. Canaan Partners led the funding round and existing investors 1315 Capital and 3D Systems also participated. Onkos will use the new funding to expand its sales, marketing, and R&D platforms to

Press Release | Jan 30, 2017

An experienced management group led by Joseph M. Limber, in partnership with Ampersand Capital Partners and 1315 Capital, has entered into a definitive agreement to acquire the commercial laboratory of Genoptix, Inc., a Novartis company that specializes in oncology diagnostics and informatics services. This transaction is expected to close in the first quarter of 2017

Pages 1 2 3 4